GSK VS CVS Stock Comparison
Performance
GSK10/100
10/100
GSK returned 3.98% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
CVS10/100
10/100
CVS returned -30.01% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
GSK63/100
63/100
4 analysts offer 12-month price targets for GSK. Together, they have an average target of 0, the most optimistic target put GSK at 0 within 12-months and the most pessimistic has GSK at 0.
CVS71/100
71/100
24 analysts offer 12-month price targets for CVS. Together, they have an average target of 113.68, the most optimistic target put CVS at 127 within 12-months and the most pessimistic has CVS at 80.
Technicals
GSK10/100
10/100
GSK receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
CVS21/100
21/100
CVS receives a 21 of 100 based on 14 indicators. 2 are bullish, 10 are bearish.
Earnings
GSK66/100
66/100
GSK has missed earnings 3 times in the last 20 quarters.
CVS100/100
100/100
CVS has missed earnings 0 times in the last 20 quarters.
Profit
GSK72/100
72/100
Out of the last 20 quarters, GSK has had 20 profitable quarters and has increased their profits year over year on 7 of them.
CVS74/100
74/100
Out of the last 20 quarters, CVS has had 18 profitable quarters and has increased their profits year over year on 9 of them.
Volatility
GSK56/100
56/100
GSK has had a higher than average amount of volatility over the last 12 months giving it a score of 56 of 100.
CVS45/100
45/100
CVS has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.
Dividend
GSK
"Dividend" not found for GSK
CVS31/100
31/100
CVS's most recent dividend was $0.50 per share, based on a share price of $68.50. It was a payout ratio of 15.52% compared to their total earnings.
All score calculations are broken down here to help you make more informed investing decisions
GSK plc American Depositary Shares (Each representing two Ordinary Shares) Summary
New York Stock Exchange / GSK
Healthcare
Drug Manufacturers - General
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
CVS HEALTH CORPORATION Summary
New York Stock Exchange / CVS
Healthcare
Medical - Healthcare Plans
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare GSK to other companies in the same or a similar industry.